This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna
Register Now
Menu
Book Now

Julio Camarero, PhD
Professor, Pharmacology and Pharmaceutical Science at University of Southern California

Agenda Sessions

  • Therapeutic Targeting of Hdm2/HmX E3 Ligase in Cancer Cells with De Novo Cyclotides

    , 09:15
    View Session

Speakers at this event

Prev
Next
John Carney
Founder and CEO
ITheranostics

See Julio Speak

Register Now